Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00594815 · OUTCOME

Total Number of Participants Who Experienced Acute Treatment Related Adverse Events

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma · Source last updated 2017-04-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
2 years

What was measured

The toxicity of this combined regimen will be measured using the NCI CTC version 2.0.

Groups in this outcome

Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma

Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine: Immunochemotherapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma52

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma52Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        52
denoms
  1. counts
    1. group Id
      OG000
      value
      52
    units
    Participants
description
The toxicity of this combined regimen will be measured using the NCI CTC version 2.0.
groups
  1. description
    Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine: Immunochemotherapy
    id
    OG000
    title
    Immunocompetent Pts With Newly Diagnosed Primary CNS Lymphoma
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
2 years
title
Total Number of Participants Who Experienced Acute Treatment Related Adverse Events
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice